Report of a European Working Group on late presentation with HIV infection: Recommendations and regional variation

Antiviral Therapy

Volumn 15, Issue SUPPL. 1, 2010, Pages 31-35

  Antinori, Andrea ^a   Johnson, Margaret ^b   Moreno, Santiago ^c   Yazdanpanah, Yazdan ^d   Rockstroh, Jürgen K ^e  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d CENTRE HOSPITALIER DE TOURCOING   (France)

^e UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD4 LYMPHOCYTE COUNT; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; PRIORITY JOURNAL; REVIEW; VIRUS DIAGNOSIS;

AIDS SERODIAGNOSIS; EUROPE; HEALTH PLANNING GUIDELINES; HEALTH POLICY; HIV INFECTIONS; HUMANS; PREVALENCE; RISK FACTORS; TIME FACTORS;

EID: 77952068949     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1525     Document Type: Review

References (13)

1. Moreno S, Mocroft A, d'Arminio Monforte A. Medical and societal consequences of late presentation. Antivir Ther 2010; 15 Suppl 1:9-15.
2. Johnson M, Sabin C, Girardi E. Definition and epidemiology of late presentation in Europe. Antivir Ther 2010; 15 Suppl 1:3-8.
3. Yazdanpanah Y, Lange J, Gerstoft J, Cairns G. Early testing for HIV - how do we prevent late presentation? Antivir Ther 2010; 15 Suppl 1:17-24.
4. Rockstroh JK, Gatell J, Landman R, Antinori A. Management of late-presenting patients with HIV infection. Antivir Ther 2010; 15 Suppl 1:25-30.
5. European AIDS Society. Guidelines: clinical management and treatment of HIV infected adults in Europe (Updated November 2009. Accessed 7 April 2010.) Available from http://www.europeanaidsclinicalsociety.org/guidelines.asp
6. Gazzard BG. British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med 2008; 9:563-608.
7. Hammer SM, Eron JJ, Jr., Reiss P, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA 2008;300:555-570.
8. World Health Organization. Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents. (Updated November 2009. Accessed 7 April 2010.) Available from http://www.who.int/hiv/pub/arv/advice/en/index.html
9. HIV in Europe - Working together for optimal testing and earlier care. 2009 Follow-up meeting conference report. 2-3 November 2009. (Updated 10 February 2010. Accessed 17 March 2010.) Available from http://hiveurope.eu/ LinkClick.aspx?fileticket=b8%2FJ9BrkqE%3D&tabid=37
10. The UK Collaborative HIV Cohort (UK CHIC) Steering Committee. Late diagnosis in the HAART era: proposed common definitions and associations with mortality. AIDS 2010; 24:723-727.
11. Gatell J. How to implement a consensus definition of 'late presentation'. HIV in Europe 2009. 1-2 November 2009, Stockholm, Sweden. Available from http://bambuser.com/channel/HIVinEurope/broadcast/314113
12. Dang T, Cavassini M. [Late diagnoses of HIV infection in 2009 in Switzerland: towards a universal HIV testing?]. Rev Med Suisse 2009; 5:727-728, 730-731. French.
13. Gazzard B, Clumeck N, d'Arminio MA, Lundgren JD. Indicator disease-guided testing for HIV - the next step for Europe? HIV Med 2008; 9 Suppl 2:34-40.